Carregant...
Differential sensitivities of the vascular K(ATP) channel to various PPAR activators
Several agonists of the peroxisome proliferator-activated receptors (PPARs) are currently used for the treatment of metabolic disorders including diabetes. We have recently shown that one of them, Rosiglitazone, inhibits the vascular ATP-sensitive K(+) (K(ATP)) channel and compromises the coronary v...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4132832/ https://ncbi.nlm.nih.gov/pubmed/23500542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2013.02.039 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|